Medical Oncology

杂志介绍

Medical Oncology杂志介绍

《Medical Oncology》是一本以English为主的未开放获取国际优秀期刊，中文名称医学肿瘤学，本刊主要出版、报道医学-ONCOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.8，最新CiteScore 指数为4.2。

本刊近期中国学者发表的论文主要有：

• ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion

  Author: Ma, Xuejiao; Chen, Jingruo; Huang, Bohan; Fu, Shiqi; Qu, Shuai; Yu, Rong; Zhao, Yuhua

• Classification of triple-negative breast cancer based on pathway enrichment levels

  Author: Liu, Qian; Wang, Xiaosheng

• P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3 beta pathway

  Author: Zhang, Zhechuan; Zhang, Yuanfeng; Zhang, Ronggui

• Downregulation of CEMIP enhances radiosensitivity by promoting DNA damage and apoptosis in colorectal cancer

  Author: Weng, Jiawen; Zhang, Yuqin; Liang, Weijie; Xie, Yuwen; Wang, Kai; Xu, Qian; Ding, Yi; Li, Yiyi

英文介绍

Medical Oncology杂志英文介绍

Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.